Epidermolysis bullosa acquisita: Efficacy of high-dose intravenous immunoglobulins

Woodley, 1989, Epidermolysis bullosa acquisita, 547 Woodley, 1988, Review and update of epidermolysis bullosa acquisita, Semin Dermatol, 7, 111 Gammon, 1991, Epidermolysis bullosa acquisita: a disease of autoimmunity to type VII collagen, J Autoimmun, 4, 59, 10.1016/0896-8411(91)90007-Y Gammon, 1990, Direct immunofluorescence studies of sodium chloride—separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita, J Am Acad Dermatol, 22, 664, 10.1016/0190-9622(90)70094-X Yaoita, 1981, Epidermolysis bullosa acquisita: ultrastructural and immunological studies, J Invest Dermatol, 76, 288, 10.1111/1523-1747.ep12526124 Kushniruk, 1973, The immunopathology of epidermolysis bullosa acquisita, Can Med Assoc J, 108, 1143 Uitto, 1992, Molecular biology and pathology of type VII collagen, Exp Dermatol, 1, 2, 10.1111/j.1600-0625.1992.tb00065.x Parente, 1991, Human type VII collagen: cDNA cloning and chromosomal mapping of the gene, Proc Natl Acad Sci USA, 88, 6931, 10.1073/pnas.88.16.6931 Lunstrum, 1987, Anchoring fibrils contain the carboxyl-terminal globular domain of type VII procollagen but lack the amino-terminal globular domain, J Biol Chem, 262, 13706, 10.1016/S0021-9258(19)76484-9 Keene, 1987, Type VII collagen forms an extended network of anchoring fibrils, J Cell Biol, 104, 611, 10.1083/jcb.104.3.611 Sakai, 1986, Type VII collagen is a major structural component of anchoring fibrils, J Cell Biol, 103, 1577, 10.1083/jcb.103.4.1577 Lunstrum, 1986, Large complex globular domains of type VII procollagen contribute to the structureofanchoringfibrils, J Biol Chem, 261, 9042, 10.1016/S0021-9258(19)84485-X Merle, 1990, Intractable epidermolysis bullosa acquisita: efficacy of Ciclosporin A, Dermatologica, 181, 44, 10.1159/000247859 Crow, 1988, Clearing of epidermolysis bullosa acquisita with cyclosporine, J Am Acad Dermatol, 19, 937, 10.1016/S0190-9622(88)70254-6 Layton, 1990, Clearing of epidermolysis bullosa acquisita with cyclosporine [Letter], J Am Acad Dermatol, 22, 535, 10.1016/S0190-9622(08)80404-5 Connolly, 1987, Treatment of epidermolysis bullosa acquisita with cyclosporine [Letter], J Am Acad Dermatol, 16, 890, 10.1016/S0190-9622(87)80239-6 Zachariae, 1987, Cyclosporine A in epidermolysis bullosa acquisita [Letter], J Am Acad Dermatol, 17, 1058, 10.1016/S0190-9622(87)80494-2 Gupta, 1990, Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses, Arch Dermatol, 126, 339, 10.1001/archderm.1990.01670270071012 Albrecht, 1992, Cyclosporine in dermatology: a pharmacological and clinical review, Dermatol Mon schr, 178, 55 Imbach, 1981, High dose intravenous gammaglobulins for idiopathic thrombocytopenia in childhood, Lancet, 1, 1228, 10.1016/S0140-6736(81)92400-4 Gajdos, 1984, High dose intravenous gammaglobulins for myasthenia gravis, Lancet, 1, 406, 10.1016/S0140-6736(84)90469-0 Roifman, 1987, Reversal of chronic polymyositis following intravenous immune serum globulin therapy, JAMA, 258, 513, 10.1001/jama.1987.03400040111034 Adoue, 1987, Utilisation de tres faibles doses d’immunoglobulines intraveineuses pour le traitement des pemphigoides huileuses, Presse Med, 16, 1625 Gordon, 1987, Intravenous immunoglobulin therapy: new directions and unanswered questions, Am J Med, 83, 52, 10.1016/0002-9343(87)90551-1